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Abstract
Sleep bruxism (SB) is a parafunctional oromotor habit that can sometimes pose a threat to the integrity of the 
structures of the masticatory system if the magnitude and direction of the forces exerted exceed the system’s 
adaptive capacity.
Over the years science has tried to provide a consistent explanation of the etiopathogenesis and physiopathology 
of SB, although the pathophysiological mechanisms are even now not yet fully understood.
There is at present no specific, effective treatment to eliminate the habit of bruxism permanently. There are only 
palliative therapeutic alternatives steered at preventing the pathological effects of SB on the stomatognathic sys-
tem and alleviating the negative clinical consequences of the habit.
The objective of this article is to review and update the fundamental scientific concepts of SB and to furnish an 
approach to the main types of therapy used, based on the scientific literature.
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Concept
Sleep bruxism (SB) is a parafunctional oromotor habit 
that can sometimes pose a threat to the integrity of the 
structures of the stomatognathic system if the magni-
tude and direction of the forces exerted exceed the sys-
tem’s adaptive capacity.
In the second International Classification of Sleep Dis-
orders (AASM 2005), SB is defined as an oromotor ac-
tivity that is characterised by the clenching or grinding 
of the teeth during sleep, is habitually associated with 
micro-arousals and is generally accompanied by sound. 
This definition has changed since the first edition of the 
International Classification, in which SB was classified 
amongst the parasomnias (abnormal behaviour present-
ing during but not interrupting sleep).
Kato and cols. affirm that SB is a parasomnia and a 
parafunctional activity during sleep that is character-
ised by clenching (tonic activity) and/or the repetition of 
phases of muscle activity (phasic activity) that produce 
grinding of the teeth (1). 
The American Academy of Orofacial Pain in 2008 de-
fined bruxism as a diurnal or nocturnal parafunctional 
Med Oral Patol Oral Cir Bucal. 2011 Mar 1;16 (2):e231-8.                                                                                                                                                                                                  Sleep bruxism
e232
activity that includes unconscious clenching, grinding 
or bracing of the teeth. Bruxism can be suspected when 
there is clear evidence of wear facets that cannot be in-
terpreted as the result of the masticatory function. The 
presence of SB can be confirmed by polysomnographic 
recording in a sleep laboratory. This definition is some-
what less precise, since it uses the terms “diurnal” and 
“nocturnal” instead of “sleep” and “waking”, which are 
more in accordance with the dynamics of life in today’s 
society (not all people sleep at night and “live” during 
the day).
Epidemiology
Sleep bruxism is a frequent habit. It is present, at least 
episodically, in a significant percentage of the popula-
tion. Nevertheless, the prevalence of SB is difficult to 
estimate because, in most cases, there are no clinical 
symptoms. In those cases where there is some clinical 
manifestation, bruxism is initially suspected due to the 
presence of symptoms reported in anamnesis by the pa-
tient or the patient’s bed partner or due to the presence 
of suspicious clinical signs.
Only polysomnography (PSG) in a sleep laboratory can 
confirm a definite diagnosis, and being PSG a very costly 
test, make the possibility of conducting cross-sectional 
studies amongst the population difficult. In addition, in 
the interpretation of a polysomnogram, there are many 
recordings of movements of the masticatory and orofa-
cial musculature (e.g., swallowing, tics, coughing) that 
may prove confusing. This point will be dealt with in 
greater detail in the discussion of diagnosis.
Furthermore it must be kept in mind that PSG studies 
are generally prescribed as complementary testing for 
the diagnosis of clinical entities that may be associated 
with SB and whose treatment may also alter the results 
of the study.
The two most-representative large-scale epidemiologi-
cal studies conducted by telephone survey coincide in 
estimating an approximate SB prevalence of 8% in the 
general population (2). The prevalence of SB in children 
is between 14 and 20%, in young persons between the 
age of 18 and 29 it is 13%, in adults it is 9% and in per-
sons over age 65 it is 3% (3-5).
Etiopathogenesis 
The etiopathogenesis of SB continues to be the grounds 
for scientific debate. Different theories have been pos-
ited in succession over the years.
Although initially SB was thought to originate as a con-
sequence of alterations in dental occlusion, the scientif-
ic literature has repeatedly proved that this theory lacks 
scientific validity (6).
At present studies seem to support the multi-factorial 
hypothesis of the genesis and pathogenesis of SB. Fac-
tors such as genetics (3), sleep structure (micro-arous-
als) (7), environment, emotional distress, anxiety and 
other psychological factors (8), the catecholaminergic 
balance of the CNS (9), the autonomic nervous system, 
and some drugs (ecstasy, alcohol, caffeine, tobacco) and 
medications (e.g., selective serotonin reuptake inhibi-
tors, benzodiazepines, dopaminergic drugs) bear a re-
lationship with the etiopathogenesis of SB.
The theories that sustain a possible genetic predisposi-
tion to SB stem mostly from studies based on question-
naires or analyses of populations of monozygotic twins 
(3, 4). These studies reveal that between 20 and 50% of 
the individuals aware that they have SB have a direct 
relative who also has SB. This relationship is especially 
significant in monozygotic twins (4). Future research 
studies are oriented toward discovering the genes and 
proteins whose expression may bear a relationship with 
the genesis of SB.
Anxiety, emotional distress, their relationship with 
the hypothalamic/hypophyseal axis (release of cat-
echolamines such as norepinephrine, epinephrine and 
dopamine) and their possible involvement in the etio-
pathogenesis of SB have also been the object of scien-
tific debate (8).
High levels of catecholamines have been detected in 
the urine of children and adults with SB and have been 
related with stress levels. Also the results of a question-
naire-based study suggest that patients with SB have a 
deficit in their capacity to adapt and react to situations 
of stress (8).
However, one study using EMG was unable to prove a 
significant association between stress and SB. Only 8% 
of the study subjects displayed a relationship between 
stressful daytime situations and SB.
Another hypothesis that attempts to explain the etio-
pathogenesis of SB is based on cerebral neurotrans-
mitters and their control over sleep/waking cycles (7, 
9), stress response and autonomic activity. Substances 
such as epinephrine, norepinephrine, dopamine, sero-
tonin and γ-aminobutyric acid (GABA) may be related 
with the genesis of rhythmic masticatory muscle activ-
ity (RMMA), although the scientific evidence is still 
weak.
It has been suggested that dopamine in the basal gan-
glia, which control mobility of the mouth, and in the 
limbic system, which is related with the processing of 
affections and emotions, may be of some importance 
in the origin of SB (10). The hypothesis is that there is 
an asymmetry in the dopamine uptake level of the D2 
receptors situated in the said nuclei. This asymmetry 
could favour the appearance of SB in stressful situations 
that stimulate the production and secretion of dopamine 
in the substantia nigra of the midbrain (mesocorticolim-
bic and nigrostriatal pathways). However, other studies 
fail to confirm this hypothesis (11, 12). In fact, L-dopa, 
a dopamine precursor, has only a modest effect on the 
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reduction of SB, and bromocriptine, a dopamine ago-
nist, has none (13).
Nor have any results been obtained that scientifically 
support the idea that serotonin plays a role in the etio-
pathogenesis of SB. Its precursor, tryptophan, and the 
use of tricyclic antidepressants that regulate serotonin 
levels in the CNS do not significantly affect the pres-
ence of SB.
The importance of the interaction amongst the no-
radrenergic, cholinergic and GABAergic neurons in the 
regulation of muscle tone in the different phases of sleep 
is known (14), as is the role that norepinephrine plays 
in maintaining alertness and wakefulness in situations 
of stress. The influence of norepinephrine on the etio-
pathogenesis of SB is supported by studies that show 
the action of clonidine, an α2-adrenergic agonist, in the 
reduction of the frequency of RMMA movements, with 
the drawback of producing severe orthostatic hypoten-
sion in 20% of the patients in the study.
Lastly, GABA is the primary CNS-inhibiting neuro-
transmitter. Although the hypothesis has been formu-
lated that GABA may play a role in SB, any relation-
ship seems to be merely indirect, since GABA is im-
plicated in almost all the neuronal systems that control 
wakefulness, sleep and motor activity. Its best-known 
pharmacological analogues, diazepam and clonazepam, 
produce a reduction of SB, but they also have severe, 
undesirable collateral effects, such as sleepiness, dizzi-
ness and risk of addiction (15).
According to the concepts explained above, SB may be 
divided into primary or idiopathic SB, that is present 
without any apparent cause, and secondary SB, due to 
traumatic injuries, diseases or sometimes pharmacolog-
ical treatments for other diseases, such as Parkinson’s 
disease (iatrogenic bruxism).
Physiopathology 
Sleep bruxism is related with RMMA (11, 12), a specific 
type of masticatory muscle activity that is characterised 
by rhythmic, pseudo-masticatory jaw movements oc-
curring once or twice per hour of sleep, at a frequency 
of approximately 1 Hz, especially in phases 1 and 2 of 
non-REM sleep. This masticatory parafunctional activ-
ity is observed in 60% of non-bruxist individuals and 
80% of patients with SB. Although it is suspected that 
RMMA may be associated with increases in salivation 
to lubricate the oropharyngeal structures or to increase 
the space of the upper airways, its physiopathological 
relationship with SB has yet to be clarified, because 
RMMA is also present in other sleep disorders, such as 
parasomnias, acid reflux during sleep, obstructive sleep 
apnoea and snoring.
Although at present the nuclei and mechanisms that 
generate RMMA are not accurately known, it is thought 
that they may in some way be related with the central 
pattern generator, a complex framework of centres situ-
ated in the frontal zone of the nucleus of the trigeminal 
nerve that is responsible for controlling rhythmic mas-
ticatory movements during wakefulness, together with 
other structures of the encephalic trunk (motor nuclei 
of the trigeminal and facial nerves, lateral zone of the 
reticular formation, caudal pontine nucleus, principal 
sensory nucleus) (14, 16).
The physiopathology of SB seems to bear some rela-
tionship with an activation of the autonomic nervous 
system, specifically the sympathetic nervous system. 
In fact, as shown in figure I, the oromotor episode of 
SB is only the final element in a chain of events that 
begins with sympathetic autonomic activation and a 
reduction of parasympathetic activity (between 8 and 
4 minutes prior to the bruxing episode), followed by 
cortical activation with the presence of α waves on the 
EEG (4 seconds prior), an increase in respiratory and 
cardiac frequency (1 second prior) and an increase in 
the tone of the mouth-opening suprahyoid muscles (0.8 
seconds prior), and ends with the bruxing episode (1, 
11). This confirms the etiopathogenic hypothesis of the 
central origin of SB, where masticatory muscle activity, 
and therefore the contact of clenching or grinding the 
teeth, are only the peripheral reflection of this central 
activation, and it invalidates occlusal theories about the 
bruxing habit and questions the occlusal odontological 
therapeutic approach.
Close to 80% of the episodes of bruxism appear in 
groups or clusters during the transition from phase 3 
to phase 2 and from phase 2 to phase 1 of non-REM 
sleep, in the passage from deep sleep to superficial sleep 
associated with micro-arousals (short-lasting three- to 
15-second periods in which there is a cortical activation 
associated with an increase in the activity of the sym-
pathetic nervous system) (11, 14). These micro-arous-
als are physiological episodes that recur during sleep, 
grouped cyclically into what is known as the cyclic al-
ternating pattern.
Sleep bruxism is observed more frequently during 
REM sleep in patients with psychiatric and/or neurolog-
ical disorders and in patients being treated with drugs 
that act on the CNS (9, 10, 13). To date polysomnog-
raphy studies have revealed that there is a relationship 
between micro-arousals (autonomic cortical activation 
preceding the activation of the musculature that 
closes the mandible) and episodes of sleep bruxism, 
suggesting that the activation of the autonomic and cen-
tral nervous systems is the primary factor responsible 
for the initiation of SB (1, 11, 12). Even so, it should be 
stressed that most bruxist patients do not report poor 
sleep quality or present alterations in polysomnography 
studies (7, 11, 12).
It was recently seen that close to 60% of the episodes 
of RMMA in patients with and without SB occurred 
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concomitantly with laryngeal movements related with 
swallowing, and in addition nearly 80% of the episodes 
of SB were associated with leg movements (1, 2, 12, 17, 
18).
Classification 
Bruxism may be classified according to several criteria 
(11):
1. By when it occurs:
a. Awake bruxism: This is presented when the indivi-
dual is awake.
b. Sleep bruxism (SB): This is presented when the indi-
vidual is asleep.
c. Combined bruxism: This is presented in both situa-
tions.
2. By aetiology:
a. Primary, essential or idiopathic bruxism:  For which 
no apparent cause is known.
b. Secondary bruxism:  Secondary to diseases (coma, 
ictus, cerebral palsy), medicinal products (e.g., antipsy-
chotic medication, cardioactive medication), drugs (e.g., 
amphetamines, cocaine, ecstasy).
3. By motor activity type:
a. Tonic:  Muscular contraction sustained for more than 
two seconds.
b. Phasic:  Brief, repeated contractions of the mastica-
tory musculature with three or more consecutive bursts 
of electromyographic activity that last between 0.25 and 
two seconds apiece.
c. Combined:  Alternating appearance of tonic and pha-
sic episodes.
Approximately 90% of the episodes of SB are phasic 
or combined, unlike in awake bruxism, where episodes 
are predominantly tonic.
4. By current or past presence:
a. Past bruxism.
b. Current or present bruxism.
They are frequently difficult to tell apart.
Fig. 1. Time sequence of physiological phenomena of micro-arousal with RMMA preceding an epi-
sode of SB.
PREDOMINANCEOFTHESYMPATHETICNERVOUSSYSTEMAND
 PREDOMINANCEOFTHEPARASYMPATHETICNERVOUSSYSTEM
 Ͳ8toͲ4min.
ACTIVATIONEEGCEREBRALCORTEX
 (ɲwaves)
 Ͳ4sec.
CARDIACANDRESPIRATORYFREQUENCY
SUPRAHYOIDMUSCLETONE
 Ͳ1sec.
TWODEEPBREATHS
 
RMMA/BRUXINGEPISODE

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Clinical Picture 
Although SB is a parafunctional oromotor activity in 
which extremely intense force vectors are sometimes 
developed, most bruxers present no pathological clini-
cal signs or symptoms (1).
In those cases where the bruxist parafunctional forces 
exceed the tolerance threshold of the masticatory sys-
tem, the functional equilibrium of the stomatognathic 
system may be altered, at which time clinical symp-
tomatology and signs of functional limitation appear, as 
shown in table 1. These signs and symptoms may give 
rise to a picture of craniomandibular disorder (19).
Diagnosis 
Clinical diagnosis on a suspicion of SB is conducted in 
patients who present with symptoms such as those de-
scribed in table 1 and in whom signs compatible with 
the bruxing habit are found. This presumed clinical di-
Table 1. Most-frequent Symptoms and Signs of SB.
agnosis must be confirmed by instrumental diagnostic 
testing (PSG, EMG, EEG).
Since many of the deleterious effects of SB (dental wear, 
fractures of teeth and restorations, non-carious cervical 
dental lesions, tongue indentations, linea alba) are per-
manent, clinically speaking it is sometimes difficult to 
ascertain whether the patient has SB at the present time 
or whether the signs are sequelae of past SB (16). 
When a patient seeks advice for a possible problem of 
SB, diagnosis must begin with the patient’s filling out a 
questionnaire containing a series of questions to orient 
the practitioner in the diagnostic process (20). Table 2 
contains an example of some such questions. Neverthe-
less, it must be borne in mind that questionnaires have 
certain limitations, given the fluctuating course of SB 
(which causes errors of under- or overestimation in re-
plies (21)) and the fact that the person who perceives 
the SB is frequently the bed partner, and because many 
Symptoms
Grinding of teeth, accompanied by a characteristic sound that - 
may even awaken the bruxer’s bed partner.
Pain in the TMJ.- 
Pain in the masticatory and cervical muscles.- 
Headache (especially in the temporal zone when the patient - 
wakes up in the morning).
Hypersensitive teeth.- 
Excessive tooth mobility.- 
Poor sleep quality. Tiredness.- 
Signs
Abnormal tooth wear.- 
Tongue indentations.- 
Linea alba along the biting plane.- 
Gum recession.- 
Presence of torus maxillaris and/or mandibularis.- 
Increase in muscle activity (This is recorded by the polysom-- 
nograph).
Hypertrophy of masseter muscles.- 
Reduction of salivary flow.- 
Breakage of fillings and/or teeth.- 
Limitation of mouth-opening ability.- 
Med Oral Patol Oral Cir Bucal. 2011 Mar 1;16 (2):e231-8.                                                                                                                                                                                                  Sleep bruxism
e236
episodes of bruxism involve only the clenching of teeth 
without grinding and therefore are soundless.
In addition to these questionnaires, the AASM proposes 
a series of criteria for the clinical diagnosis of SB:
- The patient reports clenching or grinding of teeth dur-
ing sleep
- One or more of the following clinical signs is ob-
served:
o Abnormal wear on teeth 
o Discomfort, fatigue or pain in the masticatory muscu-
lature and/or locking of the jaws on wakening
o Hypertrophy of the masseter muscles in forced volun-
tary clenching
o Masticatory muscle activity cannot be explained by 
any other sleep disorder, medical or neurological patho-
logical process, ingestion of medications or any other 
type of medicinal product or drug.
Clinically, dental wear is the first sign to indicate the 
presence of bruxism, although it does not give any infor-
mation about whether the bruxism is currently present 
or the wear is a sign of previous lesions. Furthermore, 
factors such as age, gender, occlusion, enamel hardness, 
diet, ingestion of acidic, isotonic or carbonic beverages, 
salivary flow and the presence of certain digestive dis-
orders (gastroesophageal reflux, which often presents 
subclinically) have a very important influence on the 
variability of dental wear.
Other clinical signs of SB are listed in table 1.
The diagnostic devices available at present are more use-
ful in research projects than in daily clinical use. Their 
high cost aside, the variability of presentation of SB (21) 
plus the artefacts and the annoyance caused by their ap-
plication (wires, sensors adhered to the skin, sleeping in 
an unfamiliar environment) mean that sometimes these 
tests fail to have the desired validity. Diagnosis there-
fore continues to be based fundamentally on the clinical 
judgment of the practitioner.
Sleep bruxism has been analysed using intraoral de-
vices that employ sensors to quantify clenching force 
and times of presentation. Sleep bruxism has also been 
analysed by observing the presence, distribution and 
progression of facets of wear in orthotic devices.
Portable electromyography (EMG) monitoring systems 
are another type of devices that can help in the diagno-
sis of SB. These have the advantage of moderate cost 
and the possibility of making multiple recordings in the 
patient’s regular sleeping environment (22). Neverthe-
less, their validity has not yet been scientifically dem-
onstrated in broad population groups. Because there is 
no audio/video record, ambulatory EMG devices tend 
to overestimate the presence of SB, as there are many 
motor activities (sighing, coughing, sucking) that may 
be confused with bruxism (Up to 30% of the mastica-
tory muscle activity during sleep is not SB).
The only way to diagnose the presence of current SB 
with absolute certainty is by PSG in a sleep laboratory 
- Areyouawareoffrequentlyoroccasionallyclenchingorgrindingyour
teethwhileyouareasleep?
- Hasanyoneevertoldyouyougrindyourteethwhileyouareasleep?
- Doyounoticetensionorfatigueinyourfacialmuscles,yourteethor
yourgumswhenyouwakeup?
- Haveyoueverawakenedtofindyourjawlockedandyoucouldnot
openit?
- Doyouwakeuptoaheadache,backpainorpaininthebackofyour
neck?
- Haveyounoticedwearonyourteeth?

Table 2. Examples of Questions That Can Help Diagnose SB.
- Atleasttwoepisodesofbruxismwithaudiblesounds
- Morethanfourepisodesofbruxismperhourofsleepand/or
- Morethan25burstsofbruxismperhourofsleepand/or
- Morethansixburstsofrhythmicmasticatorymuscleactivityper
episodeofbruxism

Table 3. PSG Criteria for Diagnosing SB.
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and confirmation that the patient meets the requirements 
described in the literature and listed in table 3.
A PSG test includes EEG recordings to measure brain 
activity, EMG recordings for masticatory muscle (mas-
seter and temporal) activity, EKG recordings for heart 
activity, oximetry readings to measure blood oxygen 
levels and measurers of respiratory volume and fre-
quency, in addition to audio/video recordings to rule out 
non-bruxing masticatory activity.
The greatest disadvantages of PSG are its high cost and 
its modification of the patient’s habitual sleeping en-
vironment, which means that sometimes the patient’s 
normal activity cycle is not reflected. For these reasons 
PSG is usually restricted to the diagnosis of complex 
cases (epilepsy, complex disorders of movement during 
sleep) and research purposes.
Treatment 
At present there is no treatment that effectively, perma-
nently eliminates the bruxing habit (23). For that rea-
son the therapeutic approach to SB for now is oriented 
toward palliating, albeit partially, the effect of SB and 
preventing and treating its pathological effects on the 
stomatognathic apparatus (24).
One of the most important therapeutic tools is to give 
the patient information and a detailed, simple explana-
tion of the clinical picture. Although the etiopathogen-
esis and physiopathology of SB seem to rest on central 
mechanisms that are beyond voluntary control (neuro-
transmitter activity, micro-arousals), the patient’s coop-
eration in observation of the habit during wakefulness 
and the patient’s engagement in the self-management 
of the habit through self-relaxation measures are very 
important elements for helping to reduce the frequen-
cy and intensity of masticatory muscle activity during 
wakefulness, which favours muscle relaxation and the 
reduction of bruxing episodes during sleep. If the pa-
tient does not assume responsibility for this important 
aspect of self-management in therapy and apply it, any 
other measures will be of only very limited usefulness.
There are some pharmacological compounds (botu-
linum toxin type A, benzodiazepines and other mus-
cle relaxants, anticonvulsants (25), beta blockers (15), 
dopamine and other dopaminergic drugs (13), antide-
pressants (26, 27), clonidine (15), etc.) that can help 
control SB, although their use must be restricted to non-
recurrent situations, such as the start of treatment or pe-
riods of exacerbation due to a rise in emotional tension, 
and always as part of a comprehensive, interdisciplinary 
approach.
Orthopaedic devices (oral orthotic devices) have not 
demonstrated their medium- and long-term usefulness 
in reducing masticatory muscle activity during sleep 
(28-31). Therefore at present they are indicated only 
for some clinical situations in which SB presents with 
painful muscular symptomatology and for the preven-
tion of the pathological effects of parafunctional occlu-
sal forces on teeth, the periodontium and odontological 
restorations. 
Whereas it is fully proved that there is no relationship 
between the scheme of static and dynamic occlusal rela-
tions and the etiopathogenesis and physiopathology of 
SB (6), current scientific evidence does not support the 
use of irreversible occlusal treatments (occlusal adjust-
ment through selective grinding, occlusal rehabilitation, 
orthodontics) for the treatment of SB.
Psychological therapies oriented toward controlling the 
psycho-emotional factors that may underlie SB (anxi-
ety, emotional distress), such as behavioural cogni-
tive therapy, EMG biofeedback, relaxation techniques, 
psychoanalysis, hypnosis and meditation (32-34), offer 
some favourable results, although their efficacy is still 
pending validation through studies of a high enough 
scientific caliber. 
One very important aspect of the therapeutic handling 
of SB is the study and treatment of sleep disorders, since 
improvement in the quantity and quality of sleep entails 
an important reduction in episodes of bruxism.
Some types of physical medicine (cardiovascular ton-
ing programmes, TENS, acupuncture, manual massage) 
(35-39) and alternative/naturopathic medicine (40) are 
also employed.
Conclusions 
Sleep bruxism is a parafunctional oromotor habit with 
a high prevalence in the general population. Because of 
its clinical implications, it has been and continues to be 
a point on which great attention is focused by odontol-
ogy.
Throughout history there have been series of different 
hypotheses posited to explain the etiopathogenesis and 
physiopathology of SB. At present a multi-factor etio-
logical model is accepted that includes genetic, neuro-
physiological (central neurotransmitters, sleep struc-
ture, autonomic nervous system), psycho-emotional and 
pharmacological factors.
Contrary to general belief, only a small percentage of 
bruxers develop a pathological picture as a consequence 
of the SB habit. This occurs in the cases where SB over-
steps the body’s capacity to adapt, in which event SB 
may cause craniomandibular dysfunction.
At present there is no effective treatment to eliminate 
SB permanently. Therefore the therapeutic approach is 
steered toward attempting to prevent damage and treat-
ing the pathological effects SB has on the structures of 
the masticatory system.
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